A broadband amplification that utilizes a serial hybrid fiber amplifier is experimentally demonstrated in this paper. Two fully double-pass configurations, namely, setups A and B, are implemented. The difference between these two configurations is that the position of the two amplifiers (erbium and Raman) is swapped. These two configurations are tested under the same input parameter conditions. Two laser pump power wavelengths with a total pump power of 375 mW (1495 nm with 350 mW for Raman and 1480 nm with 25 mW for the erbium amplifier) were used. Under the optimum condition and under a small signal power of -30 dBm, a wide flatness gain bandwidth of 80 nm (1530–1610 nm) with an average gain level of 28.5 and 24 dB is achieved for setups A and B, respectively. A wide bandwidth is achieved by avoiding the amplification overlap between these two amplifiers through choosing the proper pump wavelength.
In this paper, gain and noise figure of Erbium Doped Fiber Amplifier (EDFA) is analyzed based on double pass with Wave Selective Coupler (WSC). The main contribution in this study the use of a (WSC) to eliminate the residual pump power out of the signal and attain optimal result in L-band. This method decreases the self-saturation effect of ASE. Also, the study shows the effect on input and output signal power in L-band Erbium Doped Fiber Amplifiers with pump power using forward pumping. Moreover, the researchers analyzed the high-yield behavior and characterization details of the new double-pass EDFA with WSC. Finally, the study shows the effects of pump power on gain and noise figure with input and output signal power in L-band at 1590 nm.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.